Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sarcomatous Mesothelioma”

Showing 4 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00227630
What this trial is testing

Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 59
Testing effectiveness (Phase 2)WithdrawnNCT01105390
What this trial is testing

AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00053885
What this trial is testing

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 47
Large-scale testing (Phase 3)Study completedNCT00821860
What this trial is testing

Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant MesotheliomaMetastatic Cancer
Papworth Hospital NHS Foundation Trust 196

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation